Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
Authors Perwitasari DA, Febriana SA, Tristiana RS
Received 4 October 2020
Accepted for publication 19 January 2021
Published 15 February 2021 Volume 2021:15 Pages 329—335
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Johnny Chen
Dyah Aryani Perwitasari,1 Sri Awalia Febriana,2 Ratna Septi Tristiana1
1Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia; 2Department of Dermatology and Venereology, Universitas Gadjah Mada, Yogyakarta, Indonesia
Correspondence: Dyah Aryani Perwitasari
Faculty of Pharmacy, Universitas Ahmad Dahlan, Kampus 3 UAD, Jl Prof Dr Soepomo, Janturan, Yogyakarta, 55164, Indonesia
Purpose: Drug Reaction With Eosinophilia and Systemic Symptom (DRESS), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN) are acute hypersensitivity reactions with the potential to reduce the quality of life of exposed individuals. This study aims to determine the quality of life of patients suffering from DRESS, SJS, SJS/TEN.
Patients and Methods: A cross-sectional approach was used to get the quality of life data from DRESS, SJS, and/or TEN patients at Dr. Sardjito general hospital, Yogyakarta. The utility index and VAS score differences of EQ-5D-5L were analyzed based on the diagnosis.
Results: We recruited 58 patients. Most of the patients were female (63%). The mean value of utility index was 0.61, 0.08 and 0.03 for DRESS, SJS and SJS/TEN patients, respectively (p value < 0.01). Furthermore, the mean of VAS score was 73.36, 57.93 and 50.00 for DRESS, SJS and SJS/TEN patients, respectively (p value < 0.01).
Conclusion: In general, the quality of life of DRESS patients is better than the quality of life of SJS and/or TEN patients.
Keywords: DRESS, QoL, SJS, TEN, skin diseases
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]